
ROLE OF THE APOB GENE POLYMORPHISM (c.12669G>A,
p.Gln4154Lys) IN CORONARY ARTERY DISEASE IN
THE INDIAN PUNJABI POPULATION Sharma R1,*, Mahajan M2, Singh B1, Singh G3, Singh P3 *Corresponding Author: Ritu Sharma, Department of Biochemistry, Government Medical College, Circular
Road, Amritsar-143001, Punjab, India; Tel.: +91-183-257-3637; Fax: +91-183-242-6506: E-mail: ritu_gmc@
rediffmail.com page: 35
|
RESULTS
The subjects under study had either the R+R+
genotype or R+R– genotype. No individual with homozygous
mutant alleles, i.e., R–R–, was identified
(Figure 1). The frequency of R+ and R– alleles was
calculated (with an allele counting method) in control
subjects as well as in CAD patients. The frequency
of the R– allele was significantly higher (p <0.05) in
CAD patients when compared to controls.
In order to study the association of the R– allele
with CAD, variations in serum lipids, lipoprotein cholesterol
and apoB levels of CAD patients and control
subjects with different apoB genotypes were investigated
(Table 1). Total cholesterol, triglycerides, very
low-density lipo-protein-cholesterol (VLDL-C), lowdensity
lipoprotein-cholesterol (LDL-C) and highdensity
lipoprotein-cholesterol (HDL-C) levels did
not differ significantly in the subjects, whether they
were CAD patients or controls carrying the R+R+ or
R+R– APOB genotype. The data were analyzed after
segregating subjects on the basis of age and gender.
However, CAD patients with the R+R– genotype had
significantly raised (p <0.05) serum apoB levels as
compared to those having the R+R+ genotype.
Raised serum apoB levels indicate the predominance
of small dense LDL particles that are more
prone to oxidation. The MDA-LDL levels and apoB
carbonyl content of LDL did not differ significantly in
CAD patients with different APOB genotypes (Table
2). A similar trend was observed in Log triglyceride/
high-density lipoprotein-cholesterol (HDL-C) value
which was taken as an index of LDL particle size.
Overall, CAD patients had increased predominance of
small dense LDL particles resulting in their increased
oxidation. However, this observation was independent
of APOB genotypes.
|
|
|
|



 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|